| Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in … M Nauck, A Frid, K Hermansen, NS Shah, T Tankova, IH Mitha, ... Diabetes care 32 (1), 84-90, 2009 | 1561 | 2009 |
| Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, VR Aroda, BS Collins, RA Gabbay, J Green, NM Maruthur, ... Diabetes care 45 (11), 2753-2786, 2022 | 799 | 2022 |
| A European evidence-based guideline for the prevention of type 2 diabetes B Paulweber, P Valensi, J Lindström, NM Lalic, CJ Greaves, M McKee, ... Hormone and Metabolic research 42 (S 01), S3-S36, 2010 | 686 | 2010 |
| Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, VR Aroda, BS Collins, RA Gabbay, J Green, NM Maruthur, ... Diabetologia 65 (12), 1925-1966, 2022 | 524 | 2022 |
| Take action to prevent diabetes–the IMAGE toolkit for the prevention of type 2 diabetes in Europe J Lindström, A Neumann, KE Sheppard, A Gilis-Januszewska, ... Hormone and Metabolic research 42 (S 01), S37-S55, 2010 | 310 | 2010 |
| Sociodemographic and lifestyle-related risk factors for identifying vulnerable groups for type 2 diabetes: a narrative review with emphasis on data from Europe I Kyrou, C Tsigos, C Mavrogianni, G Cardon, V Van Stappen, J Latomme, ... BMC endocrine disorders 20, 1-13, 2020 | 228 | 2020 |
| Effect of sitagliptin on kidney function and respective cardiovascular outcomes in type 2 diabetes: outcomes from TECOS JH Cornel, GL Bakris, SR Stevens, M Alvarsson, WA Bax, LM Chuang, ... Diabetes care 39 (12), 2304-2310, 2016 | 212 | 2016 |
| Long‐term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2‐year results from the LEAD‐2 study M Nauck, A Frid, K Hermansen, AB Thomsen, M During, N Shah, ... Diabetes, Obesity and Metabolism 15 (3), 204-212, 2013 | 207 | 2013 |
| Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes T Tankova, N Chakarova, I Atanassova, L Dakovska Diabetes research and clinical practice 92 (1), 46-52, 2011 | 155 | 2011 |
| Insulin therapy in adults with type 1 diabetes mellitus: a narrative review A Janež, C Guja, A Mitrakou, N Lalic, T Tankova, L Czupryniak, AG Tabák, ... Diabetes Therapy 11, 387-409, 2020 | 149 | 2020 |
| The role of vaspin in the development of metabolic and glucose tolerance disorders and atherosclerosis R Dimova, T Tankova BioMed research international 2015 (1), 823481, 2015 | 135 | 2015 |
| Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes G Schernthaner, N Shehadeh, AS Ametov, AV Bazarova, F Ebrahimi, ... Cardiovascular diabetology 19, 1-17, 2020 | 130 | 2020 |
| Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations D Ziegler, S Tesfaye, V Spallone, I Gurieva, J Al Kaabi, B Mankovsky, ... Diabetes research and clinical practice 186, 109063, 2022 | 128 | 2022 |
| Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe—recommendations from the international Central-Eastern European … L Czupryniak, L Barkai, S Bolgarska, A Bronisz, J Broz, K Cypryk, ... Diabetes technology & therapeutics 16 (7), 460-475, 2014 | 118 | 2014 |
| Efficacy and safety of once-weekly semaglutide 2· 0 mg versus 1· 0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial JP Frías, P Auerbach, HS Bajaj, Y Fukushima, I Lingvay, S Macura, ... The Lancet Diabetes & Endocrinology 9 (9), 563-574, 2021 | 117 | 2021 |
| A school-and community-based intervention to promote healthy lifestyle and prevent type 2 diabetes in vulnerable families across Europe: design and implementation of the … Y Manios, O Androutsos, CP Lambrinou, G Cardon, J Lindstrom, ... Public Health Nutrition 21 (17), 3281-3290, 2018 | 103 | 2018 |
| Education and quality of life in diabetic patients T Tankova, G Dakovska, D Koev Patient Education and Counseling 53 (3), 285-290, 2004 | 101 | 2004 |
| Education of diabetic patients—a one year experience T Tankova, G Dakovska, D Koev Patient education and counseling 43 (2), 139-145, 2001 | 97 | 2001 |
| Diabetes as a case study of chronic disease management with a personalized approach: the role of a structured feedback loop A Ceriello, L Barkai, JS Christiansen, L Czupryniak, R Gomis, K Harno, ... Diabetes research and clinical practice 98 (1), 5-10, 2012 | 92 | 2012 |
| Assessment of HbA1c as a diagnostic tool in diabetes and prediabetes T Tankova, N Chakarova, L Dakovska, I Atanassova Acta diabetologica 49, 371-378, 2012 | 89 | 2012 |
